HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zihan Ma Selected Research

Leucine (L-Leucine)

12/2022Nidogen-2 is a Novel Endogenous Ligand of LGR4 to Inhibit Vascular Calcification.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Zihan Ma Research Topics

Disease

3Atherosclerosis
01/2023 - 11/2020
3Neointima
01/2023 - 10/2021
2Neoplasms (Cancer)
01/2023 - 12/2020
1Wound Infection (Wound Infections)
09/2023
1Diabetes Mellitus
08/2023
1Hypertension (High Blood Pressure)
08/2023
1Emergence Delirium
08/2023
1Sleep Wake Disorders
08/2023
1Frailty
08/2023
1Lupus Nephritis
01/2023
1Rupture
01/2023
1Thoracic Aortic Aneurysm
01/2023
1Bacterial Infections (Bacterial Infection)
01/2023
1Cardiovascular Diseases (Cardiovascular Disease)
01/2023
1Coronary Artery Disease (Coronary Atherosclerosis)
01/2023
1Wounds and Injuries (Trauma)
01/2023
1Hyperplasia
01/2023
1Ischemia
01/2023
1Chronic Kidney Failure (Chronic Renal Failure)
12/2022
1Vascular Calcification
12/2022
1Abdominal Aortic Aneurysm
03/2022
1Inflammation (Inflammations)
03/2022
1Vascular System Injuries
10/2021
1Neuralgia (Stump Neuralgia)
01/2021
1Tics (Tic)
01/2021
1Neoplasm Metastasis (Metastasis)
12/2020
1Stomach Neoplasms (Stomach Cancer)
12/2020
1Vascular Remodeling
01/2020
1Vascular Diseases (Vascular Disease)
01/2020

Drug/Important Bio-Agent (IBA)

4Proteins (Proteins, Gene)FDA Link
01/2023 - 01/2020
3Metalloproteases (Metalloproteinases)IBA
01/2023 - 01/2020
2ThrombospondinsIBA
01/2023 - 01/2023
2Apolipoproteins E (ApoE)IBA
01/2023 - 11/2020
2DisintegrinsIBA
01/2023 - 01/2023
1PesticidesIBA
09/2023
1pristane (pristan)IBA
01/2023
1VaccinesIBA
01/2023
1anticomplementIBA
01/2023
1LipidsIBA
01/2023
11,3,4,6- tetra- O- acetyl- 2- azido- 2- deoxyglucopyranose (TAAD)IBA
01/2023
1Peptide Hydrolases (Proteases)FDA Link
01/2023
1Polysaccharides (Glycans)IBA
01/2023
1LDL Receptors (LDL Receptor)IBA
01/2023
1Protein Subunit VaccinesIBA
01/2023
1Complement Factor H (Factor H)IBA
01/2023
1Complement System Proteins (Complement)IBA
01/2023
1ElastinIBA
01/2023
1Leucine (L-Leucine)FDA Link
12/2022
1Cholecalciferol (Vitamin D3)FDA Link
12/2022
1LigandsIBA
12/2022
1Membrane Proteins (Integral Membrane Proteins)IBA
12/2022
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
12/2022
1ProhibitinsIBA
10/2022
1InflammasomesIBA
03/2022
1naringeninIBA
03/2022
1Glycoproteins (Glycoprotein)IBA
10/2021
1nidogen (entactin)IBA
10/2021
1Antipsychotic Agents (Antipsychotics)IBA
01/2021
1QuercetinIBA
01/2021
1N 3389IBA
01/2021
1Tiapride HydrochlorideIBA
01/2021
1Protein Kinases (Protein Kinase)IBA
12/2020
1Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
12/2020
1AnkyrinsIBA
12/2020
1Competitive Endogenous RNAIBA
12/2020
1Circular RNAIBA
12/2020
1MicroRNAs (MicroRNA)IBA
12/2020
1Esomeprazole (Nexium)FDA Link
12/2020
1Proton Pump InhibitorsIBA
12/2020
1Long Noncoding RNAIBA
12/2020
1Messenger RNA (mRNA)IBA
12/2020
1FlavonoidsIBA
11/2020
1CholesterolIBA
11/2020
1naringinIBA
11/2020
1Biomarkers (Surrogate Marker)IBA
01/2020

Therapy/Procedure

1Arthroplasty
08/2023
1Ligation
01/2023
1Therapeutics
01/2023
1Stents
01/2023
1Nephrectomy
12/2022